NORML

MARCH 3, 2021

“In US markets, Mexican marijuana has largely been supplanted by domestic-produced marijuana. CBP marijuana seizures along the SWB have decreased more than 81 percent since 2013,".

DEA 246

DEA Law Legalization Marijuana 246

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 340

Cultivation DEA Clinical Trials Marijuana 340

NORML

JUNE 3, 2020

If you haven’t read our statement on the murder of George Floyd and the intersections of marijuana criminalization and racial justice, please take a moment to do so here. To be clear, the DEA is not asserting its existing authority to arrest those participating in peaceful protests who may be in violation of federal drug laws.

DEA 278

DEA Law Marijuana Events 278

NORML

AUGUST 2, 2019

A federal court has ordered the Drug Enforcement Administration to respond to a lawsuit charging the agency with failing to move forward with a 2016 policy to expand the total number of federally licensed marijuana cultivators. “[This filing is] asking the court for an order compelling the DEA to process our application.

DEA 216

DEA Cultivation Marijuana Policy 216

NORML

OCTOBER 1, 2024

The post NORML Files Notice of Intent to Participate in DEA’s Marijuana Rescheduling Hearing appeared first on NORML. "We believe NORML has well earned a seat at the table, and that it is in the public interest for it to be heard."

DEA 315

DEA Marijuana Advocacy 315

NORML

JUNE 16, 2022

The totals are the highest reported by the agency since 2011, when it reported making an estimated 8,500 marijuana-related arrests and seized some 6.7 The post DEA Reports Significant Uptick in Marijuana-Related Seizures, Arrests appeared first on NORML. million plants via its domestic eradication program.

DEA 190

DEA Marijuana Programs Law 190

NORML

MAY 23, 2023

million cultivated marijuana plants in 2022. The post DEA Reports More Marijuana Seizures, Fewer Arrests in 2022 appeared first on NORML. Federal law enforcement agents and their partners seized nearly 5.7 This is the highest annual seizure total reported by the agency since 2011.

DEA 187

DEA Marijuana Cultivation Law 187

NORML

JULY 16, 2019

Federal agents seized fewer total marijuana plants in 2018, but made more arrests for cannabis-related offenses, according to annual data compiled by the US Drug Enforcement Administration. million marijuana plants nationwide in 2018. million marijuana plants nationwide in 2018. million in 2017 to 1.4 million in 2018.

DEA 178

DEA Marijuana Data Retail 178

NORML

AUGUST 26, 2019

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 193

DEA Cultivation Compliance Compliance 193

NORML

MARCH 25, 2025

Now its time for Congress to do so by repealing the failed policy of federal marijuana prohibition. The post Number of Federal Offenders Charged with Marijuana Trafficking Hits Record Low appeared first on NORML.

Marijuana 193

Marijuana Policy Law Legalization 193

Leafly

JUNE 8, 2020

The DEA's five-part test to determine 'currently accepted medical use' is flawed, say the plaintiffs. The post New lawsuit aims to force DEA to reschedule marijuana appeared first on Leafly.

DEA 145

DEA Marijuana Cannabis 145

Medical Marijuana Pages

OCTOBER 9, 2024

DEA Potential Reclassification of Marijuana Policy. In recent discussions surrounding drug policy reform, the reclassification of marijuana by the Drug Enforcement Administration (DEA) has emerged as a pivotal issue. Read More

DEA 122

DEA Policy Marijuana Cannabis 122

NORML

JANUARY 16, 2020

Federal prosecutions for marijuana-related crimes fell significantly from September 30, 2018 to September 30, 2019, according to a recently released report from Supreme Court Justice John Roberts. The 2019 end-of-year report finds that the number of federal defendants charged with cannabis-associated crimes declined by 28 percent.

DEA 247

DEA Marijuana Data Cannabis 247

NORML

SEPTEMBER 11, 2020

Of the several experts who were part of our regular “road show” at NORML during the 1970s, I wanted to focus today on two of them who were both unexpected and wonderfully effective -- Dr. Dorthy Whipple and former DEA Deputy Director John Finlator.

Decriminalization 225

Decriminalization DEA Marijuana 225

NORML

DECEMBER 7, 2020

"Legislative action is necessary in this arena because the DEA has proven time and time again that it is not an honest broker in this process.". The post House of Representatives to Vote on Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products appeared first on NORML.

Legislation 241

Legislation DEA Marijuana 241

Canna Care Docs

OCTOBER 10, 2024

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. Understanding current drug scheduling for cannabis The DEA classifies drugs, substances, and certain chemicals used to make drugs into five distinct categories or “schedules.”

Patients 111

Patients DEA Research and Development Recreational 111

NORML

MARCH 1, 2019

The American Psychological Association (APA) is urging US Attorney General William Barr to review more than two-dozen pending applications for federal marijuana grow licenses. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. Also on Wednesday, Rep.

DEA 194

DEA Research and Development Clinical Trials Marijuana 194

Americans for Safe Access

JUNE 2, 2020

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.

Clinical Trials 264

Clinical Trials DEA History Programs 264

Medical Marijuana Program Connection

MAY 4, 2024

The debate over the classification of marijuana has taken a dramatic turn. In a groundbreaking move, the Drug Enforcement Administration (DEA) has proposed to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). The historic decision, supported by the top federal health agency, marks a.

DEA 95

DEA Marijuana 95

NORML

MARCH 26, 2020

The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. ” He added, “Further, the DEA has an incredibly poor track record in this arena – having for years now promised to expedite and streamline this process, but failing to deliver.

Cultivation 242

Cultivation DEA Extraction THC 242

NORML

MAY 2, 2024

The post Federal Marijuana Rescheduling Announced appeared first on NORML. Perhaps most tellingly, our political opponents are also touting its significance, pledging to take whatever steps necessary to derail this proposed policy change.

Marijuana 315

Marijuana Policy DEA 315

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Less dangerous than marijuana, according to the CSA Schedule, are methamphetamine, cocaine, and hydrocodone. NORML launched the first petition to reschedule marijuana in 1972.

DEA 108

DEA Marijuana History Cannabis 108

WeedAdvisor

JULY 4, 2019

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety. A Vicious Circle.

DEA 111

DEA Research and Development Clinical Trials Cultivation 111

Project CBD

MARCH 7, 2025

According to the study’s THC equivalency scale, the average amount of THC in tested vapes was 2,682 milligrams per cartridge 268% above Californias limit for THC in adult-use cannabis vape products, which is 1,000 milligrams, and also well above the cap for such products under the state medical marijuana program, which is 2,000.

Hemp 230

Hemp Vaping THC Cannabinoids 230

NORML

JULY 15, 2020

Of eligible respondents, 72 percent agreed with the statement, “Medical marijuana should be used to reduce the use of opioids for non-cancer pain.” Sixty-three percent of respondents also agreed, “The DEA should reclassify marijuana so that it is no longer a schedule I drug.".

Chronic Pain 246

Chronic Pain Patients DEA Marijuana 246

Cannabis Law Report

SEPTEMBER 1, 2021

Marijuana Moment reports. In its response, the agency argued that marijuana has no currently accepted medical value. Lawyers for the group appealed that decision, asking the court to order DEA to initiate a formal rulemaking process, which would involve expert testimony and public comment. Read the full article at .

DEA 109

DEA Marijuana Policy Cannabis 109

Cannabis Law Report

OCTOBER 27, 2020

A vague memory tells us that the DEA were looking for a contractor early 2019 ? Marijuana Moment has … Read More. The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor.

DEA 98

DEA Law Marijuana Cannabis 98

Cannabis Cheri

DECEMBER 17, 2021

One of the major objections to the medicinal use of marijuana is the use of smoking as a delivery system. Based on the fact that smoking tobacco causes deterioration of lung function, these detractors intone that smoking marijuana is just as harmful. So let’s examine the truth about the effects of smoking marijuana and lung health.

Marijuana 246

Marijuana Media Patients DEA 246

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We BRC) told The Cannigma this week. Junk’ cannabis ‘ill-suited for clinical trials’. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. On Monday, the U.S.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

SEPTEMBER 25, 2024

"Hundreds of thousands of Americans continue to be arrested annually for low-level cannabis-related violations even though a majority of voters no longer believe that the responsible use of marijuana by adults should be a crime.”

Marijuana 300

Marijuana DEA Cannabis Legalization 300

The Fresh Toast

MARCH 14, 2022

DEA Delays Production Of Marijuana Drug As Potential Treatment For MS And Huntington’s Disease. The DEA application process is being delayed for years for reasons unknown. The post DEA Delays Production Of Marijuana Drug As Potential Treatment For MS And Huntington’s Disease appeared first on The Fresh Toast.

DEA 89

DEA Treatment Marijuana 89

Veriheal

OCTOBER 20, 2021

Drug Enforcement Administration (DEA) has proposed dramatically raised levels of legal cannabis and psychedelic production in 2022 for use in studies. After already increasing production quotas for 2021, the DEA is calling for a 60% increase in marijuana production. million grams, according to reporting by Marijuana Moment.

DEA 98

DEA Cultivation Cannabis Marijuana 98

NORML

SEPTEMBER 16, 2024

"These audio recordings reinforce the fact that the federal government's decision to strictly criminalize marijuana was primarily a political one," NORML's Deputy Director Paul Armentano said.

Marijuana 310

Marijuana DEA 310

NewsMunchies

MAY 20, 2021

Federal Government – granted a monopoly on the production of medical marijuana for research purposes to the University of Mississippi. This action by the DEA means researchers will be able to study marijuana from more than one grower. Marijuana continues to be prohibited under federal law. for over 50 years.

DEA 98

DEA Chronic Pain Terpenes Packaging 98

NORML

OCTOBER 21, 2019

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 102

DEA Cultivation Clinical Trials Policy 102

Cannabis Law Report

MARCH 24, 2020

The USA’s Drug Enforcement Administration and Department of Justice have published a Notice of Proposed Rulemaking regarding scientific and medical research on marijuana. Last September, it indicated it would “facilitate and expand” scientific and medical marijuana research and last week saw another tentative step in that direction.

DEA 80

DEA Marijuana Extraction Strains 80